Uncategorized

Trial By Error: A Letter to KCL, Another Letter to BMJ

By David Tuller, DrPH Last week, I wrote about a troubling press release issued by King’s College London regarding a major study of cognitive behavioural therapy as a treatment for so-called dissociative seizures. On Friday, I sent a letter to the two communications people listed on the press release about the study, as well as […]

Trial By Error: A Letter to KCL, Another Letter to BMJ Read More »

Trial By Error: A King’s College London Press Release Hides the Bad News

By David Tuller, DrPH In teaching courses on covering public health and medical issues, I have often highlighted how university press releases about studies can read like efforts at obfuscating problematic findings rather than providing an accurate account of research. A recent press release from King’s College London, about a high-profile study published by Lancet

Trial By Error: A King’s College London Press Release Hides the Bad News Read More »

Trial By Error: A Couple of Blog Posts Worth Reading

By David Tuller, DrPH I’ve been writing about so-called “medically unexplained symptoms,” or MUS, for the last couple of years. Much of that has come in the form of critiques of specific studies making excessive claims about the healing powers of cognitive behavior therapy. Recently, a blogger named Goodelf has posted a couple of revealing

Trial By Error: A Couple of Blog Posts Worth Reading Read More »

Trial By Error: Letter to BMJ Paediatrics Open About that CBT-Music Therapy Study

By David Tuller, DrPH UPDATE: I sent the following correction to Dr Choonara shortly after sending the letter of concern. Dear Dr Choonara: I wanted to make a slight correction in point #3 below. The first sentence should have read: “Why was the outcome of recovery not mentioned in the trial registration and statistical analysis

Trial By Error: Letter to BMJ Paediatrics Open About that CBT-Music Therapy Study Read More »

A mouse model for COVID-19

Small animal models (mice, ferrets, hamsters) are essential for understanding how SARS-CoV-2 causes disease and for pre-clinical evaluation of vaccines and antiviral therapeutics. One promising model has been developed by modifying SARS-CoV-2 so that it binds to murine ACE2. Laboratory mice cannot be infected with SARS-CoV-2 because the viral spike glycoprotein (illustrated) does not bind

A mouse model for COVID-19 Read More »

Trial by Error: Tack’s Take on BMJ’s CBT-Music Therapy “Feasibility Study”

By David Tuller, DrPH I have always made it clear that I pay attention when smart patients assess bad research. That’s how I stumbled into this whole mess in the first place–by reading what patients were writing about the PACE trial. (In that case, I at first dismissed the concerns when I read about how

Trial by Error: Tack’s Take on BMJ’s CBT-Music Therapy “Feasibility Study” Read More »

Scroll to Top